Carbon tetrachloride

NIMML Institute Presents Pioneering Research on Immunometabolic Mechanisms Related to the Pharmacological Activation of LANCL Receptors at Immunology2024, the Annual Meeting of the American Association of Immunologists

Retrieved on: 
星期三, 四月 10, 2024
Health Technology, Other Health, Technology, Pharmaceutical, Oncology, Mental Health, Philanthropy, Infectious Diseases, Genetics, Artificial Intelligence, Clinical Trials, Foundation, Biotechnology, Science, Research, Health, Eosinophilia, Bronchial hyperresponsiveness, NIMML, Swelling, Choline, PBMC, Gastrointestinal tract, Macrophage, Fibrosis, Red, Atopic dermatitis, Brain, TNF, Inflammation, Phenotype, Abstract, Glycolysis, Lupus, T helper 17 cell, IBD, AAI, Psoriasis, OVA, MASH, Plasma, Fed, Ulcerative colitis, Mouse, COL1A1, Microglia, McCormick Place, Therapy, Carbon tetrachloride, HDM, Immunoglobulin E, IL-6, Medicine, Asthma, House, Neutrophil, Patient, Phagocytosis, Ovalbumin, Rheumatoid arthritis, LANCL2, CDAA, UC

The AAI meeting will take place at McCormick Place in Chicago, Illinois from May 3 to May 7, 2024.

Key Points: 
  • The AAI meeting will take place at McCormick Place in Chicago, Illinois from May 3 to May 7, 2024.
  • “We are pleased to present our most recent findings related to the immunometabolic mechanisms of activation of LANCL receptors in inflammation & immunology at this year’s AAI Annual Meeting,” said Dr. Josep Bassaganya-Riera, President and Founding Director of NIMML.
  • NImmune’s portfolio includes first and best-in-class omilancor and NIM-1324, two oral, once-daily agonistic therapeutics that bind and activate the LANCL2 pathway.
  • Title: Pharmacological activation of LANCL2 provides immunometabolic support for the restoration of cognitive function markers in a mouse model of Alzheimer’s disease.

Acetonitrile Global Market Report 2023: Increasing Demand from Various End-User Industries Boosts Growth

Retrieved on: 
星期三, 二月 22, 2023
Ammonia, Natural gas, EFPIA, Adhesive, Ethanol, Application, Carbon tetrachloride, HPLC, Solvent, European Federation of Pharmaceutical Industries and Associations, Acetone, Purpose, Toxicity, Ether, Growth, International Energy Agency, Environment, IEA, Electronics, Brenntag, Ethyl lactate, Competition, Chloroform, Matrix (chemical analysis), Water, United States of Europe, Fine chemical, Queen's University Belfast

The global acetonitrile market is expanding due to continuous demand from different end-user industries, such as pharmaceuticals, specialty chemicals, electronics, HPLC applications, and biotechnological applications.

Key Points: 
  • The global acetonitrile market is expanding due to continuous demand from different end-user industries, such as pharmaceuticals, specialty chemicals, electronics, HPLC applications, and biotechnological applications.
  • Queen's University Belfast states that the pharmaceutical industry captures 70% of the global acetonitrile market.
  • One of the primary factors driving the global acetonitrile market is the increasing use of acetonitrile in pharmaceutical and analytical sector applications.
  • In this report, Global Acetonitrile Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Therapeutic Solutions International Creates Disease Specific Therapeutic Platform Based on Gene Editing/Engineering of Inducible Pluripotent Stem Cells

Retrieved on: 
星期四, 七月 28, 2022
Biotechnology, Health, Genetics, Stem Cells, Clinical Trials, Immunity, Regenerative medicine, CEO, Intellectual property, IPSC, Stem cell, COVID-19, Liver injury, Coronavirus Scientific Advisory Board (Turkey), Cell, Interleukin, Immunotherapy, Technology, Disease, Company, Phase, Carbon tetrachloride, B cell, Vaccine, Pharmaceutical industry

Therapeutic Solutions International reported the successful generation of gene-edited and/or gene-modified regenerative cells possessing mixtures of properties between mesenchymal stem cells and tolerance inducing immune cells.

Key Points: 
  • Therapeutic Solutions International reported the successful generation of gene-edited and/or gene-modified regenerative cells possessing mixtures of properties between mesenchymal stem cells and tolerance inducing immune cells.
  • The cellular platform allows for creation of cells that are unique to the disease indication and provide a combination of regenerative as well as tolerogenic activities.
  • Utilizing iPSC technology, we have been able to generate mesenchymal-like stem cells that are specific for particular disease indications.
  • Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

Insights on the Chloromethane Global Market to 2028 - Rising Demand as a Chemical Intermediate is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
星期四, 七月 7, 2022
Chemicals, Plastics, Health, Other Construction & Property, Manufacturing, Construction & Property, Pharmaceutical, Chloromethane, Carbon tetrachloride, Dichloromethane, Growth, CAGR, Chloroform, Government, Renewable energy, Chemical, Marketing

The global chloromethane market is projected to witness a considerable growth rate by exhibiting a CAGR of 4.8% during the forecast period.

Key Points: 
  • The global chloromethane market is projected to witness a considerable growth rate by exhibiting a CAGR of 4.8% during the forecast period.
  • The major factors driving the growth of the global market include its rising demand as a chemical intermediate, silicone polymer production, and butyl rubber.
  • Easy availability and growing demand for chloromethane derivatives such as chloroform, methylene chloride, and carbon tetrachloride are propelling the market growth.
  • Emerging demand from end-user industries, such as silicone intermediates, agriculture chemicals, butyl rubber, personal care, and pharmaceuticals, are fueling the growth of the global chloromethane market.

With Market Size Valued at $181.9 Million by 2026, it`s a Healthy Outlook for the Global Carbon Disulfide Market

Retrieved on: 
星期五, 六月 17, 2022
Carbon, Refrigeration, CAGR, Iodine, Rubber industry in Malaysia, Marketing, Health, Mining, Carbon tetrachloride, Fertilizer, Intelligence, Cellophane, Sulfur, Investment, Merck Group, Phosphorus, GFS Chemicals, Confusion, Industry, COVID-19, Players, Fats, Cellulose, Insecticide, Ammonia, Food packaging, Carbon disulfide, Forecasting, GIA, Research, Growth, Speciality chemicals, Migraine, Bromine, Lyocell, Selenium, SAN, Renewable energy, Tedia

The carbon disulfide market is slated to benefit from growing demand for fertilizers across developing countries to push agricultural yield.

Key Points: 
  • The carbon disulfide market is slated to benefit from growing demand for fertilizers across developing countries to push agricultural yield.
  • The carbon disulfide market is expected to also receive an impressive contribution from increasing demand of the compound for fertilizer production.
  • In terms of purity, the carbon disulfide market is segregated into pure and impure compound, with the latter holding the commanding share of the global market.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

CymaBay Therapeutics Announces Presentations During The International Liver Congress™ 2022

Retrieved on: 
星期三, 六月 8, 2022
Woman, Conditional sentence, Itch, Congress, Alkaline phosphatase, University, NL, Seladelpar, Fibrosis, Carbon tetrachloride, EASL, European Association for the Study of the Liver, Liver cancer, Farnesoid X receptor, Hepatitis, Fatigue, Thyroid hormone receptor, Doctor of Philosophy, Peroxisome, Associate, Priority, Bile, Annual report, Security (finance), Disease, U.S. Securities and Exchange Commission, Inflammation, Cholestasis, Primary biliary cholangitis, ALP, Gene, CA, Telmisartan, Lipid metabolism, PBC, Therapy, Patient, Thyroid, THR, Risk, University of California, San Diego Performance-Based Skills Assessment, Food and Drug Administration, NASDAQ, European Medicines Agency, Twitter, Association, Erasmus MC, LinkedIn, FXR, Medical device, Pharmaceutical industry, Copper, Biostatistics, GLOBE, Liver

NEWARK, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that multiple seladelpar presentations will be delivered during The International Liver Congress 2022 of the European Association for the Study of Liver (EASL) which will be held in London, UK from June 22nd 26th.

Key Points: 
  • NEWARK, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that multiple seladelpar presentations will be delivered during The International Liver Congress 2022 of the European Association for the Study of Liver (EASL) which will be held in London, UK from June 22nd 26th.
  • Dr. Dennis Kim, Chief Medical Officer of CymaBay Therapeutics, commented, We are excited to have the opportunity to present once again this year at the International Liver Congress.
  • Presentations at The International Liver Congress 2022 include:
    Congress attendees can visit CymaBay throughout the meeting at booth 93.
  • A full list of presentations can be found on The International Liver Congress 2022 website.

Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model

Retrieved on: 
星期二, 十二月 29, 2020
Branches of biology, Biology, Chemical compounds, Cell biology, Organ failure, Biotechnology, Cloning, Developmental biology, Stem cell, Liver, Carbon tetrachloride, Necrosis

PHOENIX, Dec. 29, 2020 /PRNewswire/ --(OTC-CELZ)Creative Medical Technology Holdings Inc. announced today novel data and patent filing No.

Key Points: 
  • PHOENIX, Dec. 29, 2020 /PRNewswire/ --(OTC-CELZ)Creative Medical Technology Holdings Inc. announced today novel data and patent filing No.
  • 63131261 describing the ability of ImmCelz to reverse liver failure in the carbon tetrachloride preclinical model of hepatocyte necrosis.
  • "ImmCelz is an advancement on our previous liver failure work due to the fact that we have shown transfer of regenerative activity from the stem cell to the immune cell.
  • See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov .

European Union Carbon Tetrachloride Markets, 2013-2017 & 2018-2023 - ResearchAndMarkets.com

Retrieved on: 
星期二, 四月 9, 2019
Manufacturing, Chemicals, Plastics, Chemical compounds, Chemistry, Halides, Tetrachloride, Carbon tetrachloride, European Union, Marketplace

The "Carbon Tetrachloride: European Union Market Outlook 2018 and Forecast till 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Carbon Tetrachloride: European Union Market Outlook 2018 and Forecast till 2023" report has been added to ResearchAndMarkets.com's offering.
  • The report grants access to the in-depth insight into the market of carbon tetrachloride.
  • The report sheds light on the present market situation and prospects for the market development in the upcoming years.
  • Comprehensive investigation of the European Union market of carbon tetrachloride, focusing on the overall EU market as well as country markets
    Historical and present market statistics, future market outlook
    In-depth coverage of market characteristics: information on production and consumption trends, prices and trade dynamics (EU total and by country)
    Carbon Tetrachloride market prospects (including production, consumption and price changes)